ReviewJournal of autoimmunity2020

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Bingwen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.